JNJ Dividend Yield Comparison and Evaluation

Johnson & Johnson's dividend yield is an attractive feature for income investors. At 2.73%, it's significantly higher than the S&P 500's average dividend yield of 1.87%.

In comparison to other healthcare stocks, JNJ's dividend yield stands out. For example, Pfizer's dividend yield is 3.52%, but its dividend growth has been slower than JNJ's over the past decade.

JNJ's consistent dividend growth has earned it a spot on the S&P 500 Dividend Aristocrats list. This distinction is reserved for companies with 25+ years of consecutive dividend increases.

JNJ's dividend yield is also competitive with other large-cap stocks in the S&P 500.

Suggestion: Marketability of Stocks and Bonds Is

Dividend yield is a crucial metric for investors to understand, especially when it comes to Johnson & Johnson. The current dividend yield of Johnson & Johnson is 3.32%.

To put this into perspective, a higher dividend yield generally indicates that the company is distributing a larger portion of its earnings to shareholders. This can be attractive to income-seeking investors.

On a similar theme: Investors Assess Cash Flows before

Johnson & Johnson's dividend yield is higher than the average yield of the S&P 500, which is a benchmark for the overall stock market.

A dividend yield of 3.32% means that for every $100 invested in Johnson & Johnson, investors can expect to receive approximately $3.32 in dividend payments each year.

Johnson & Johnson's dividend yield is 3.32%, which is higher than the Healthcare sector average of 1.95%.

The company's dividend yield is 70% higher than the Healthcare sector average, making it a more attractive option for income investors.

Historically, Johnson & Johnson's dividend yield has averaged at 2.7% in the last 5 years, which is less than the current yield of 3.32%.

This indicates that the company's current dividend yield is relatively high compared to its historical average.

Johnson & Johnson's dividend yield is more than the Healthcare sector average, making it a good option for investors seeking higher income.

Curious to learn more? Check out: Fdi Occurs When a Company Invests in Facilities

The dividend yield of JNJ has been steadily increasing over the years, reaching a high of 3.5% in 2020. This is due to the company's consistent dividend payments and share price growth.

JNJ's dividend yield has averaged around 3.2% over the past decade, providing a relatively stable source of income for investors. This is a key factor in the company's appeal to income-seeking investors.

The dividend payout ratio of JNJ is around 50%, indicating that the company is generating sufficient earnings to support its dividend payments.

For another approach, see: Fixed Income Attribution Analysis

The dividend payout ratio is a key metric to understand when analyzing a company's dividend yield. Johnson & Johnson's dividend payout ratio is 81.4%.

This means that out of every dollar the company earns, 81.4 cents is paid out as dividends.

Explore further: Portfolio Visualizer Omega Ratio

Johnson & Johnson's dividend yield is 3.32%, which is a relatively stable figure. This means that for every $100 invested in the company's stock, investors would receive $3.32 in dividends per year.

The company's dividend payout ratio is 81.4%, indicating that a significant portion of its earnings are being returned to shareholders. This is a positive sign of the company's financial stability and ability to pay consistent dividends.

Here's a comparison of Johnson & Johnson's dividend yield with its peers:

The company's annual dividend is $4.91 per share, which is a significant amount considering the dividend yield.

Johnson & Johnson's dividend yield is around 3.5%, making it a solid choice for income investors. This is due in part to its long history of increasing dividends, having raised its dividend for at least 25 consecutive years.

The company has a dominant global market position, with a $294 billion market cap and $66 billion in revenue, eclipsing its closest competitor, Novartis. This strong revenue stream can help support the dividend.

Johnson & Johnson's business model is easy to grasp, with a wide range of products that are household names. As master investor Peter Lynch once said, "buy what you know" has its charms.

If this caught your attention, see: Enterprise Value vs Market Cap

However, the company's dividend payout ratio has shot up due to pricey litigation and product recalls. This has led to a decline in profits, making it essential for Johnson & Johnson to get its operational act together soon.

Having over $30 billion in cash is a nice safety net for the company, but if earnings growth continues to sputter, the dividend could become a strategic drag. This is because the dividend obligations currently amount to 46% of its free cash flow, the highest level in 10 years.

Johnson & Johnson's dividend payout ratio is a crucial metric to understand, and it's currently at 81.4%. This means that 81.4% of the company's net income is being used to pay dividends.

Let's look at how this compares to its peers. Pfizer's payout ratio is a staggering 221.1%, while Gilead Sciences has a payout ratio of 3,080%. In contrast, Johnson & Johnson's payout ratio is relatively modest.

Recommended read: Dividend Yield Ratio Interpretation

Here's a breakdown of the payout ratios for various pharmaceutical companies:

The payout ratio is an important indicator of a company's financial health and its ability to sustain its dividend payments. A high payout ratio may indicate that a company is relying too heavily on its dividend payments, which could be a concern for investors.

JNJ has a dividend yield of 3.32%, which is higher than the Healthcare sector average but lower than the industry average. This indicates that JNJ's dividend yield is attractive compared to its peers.

Historically, JNJ's dividend yield has averaged 2.7% over the last 5 years, which is less than the current yield of 3.32%. This suggests that the current yield is relatively higher than the company's historical average.

Here's a breakdown of JNJ's dividend yield performance over the past 12 months:

JNJ's dividend yield has been consistently above the industry average over the past few years, making it an attractive option for income investors.

Johnson & Johnson has a long history of paying consistent dividends to its shareholders, with a strong track record of growth over the past few decades.

The company's dividend payments per share have averaged 4.47% over the past 12 months, indicating a relatively stable and consistent dividend yield.

Over a longer period, JNJ's dividend growth has been impressive, with an average of 5.43% over the past 36 months and 5.54% over the past 60 months.

This sustained growth is a testament to the company's financial stability and profitability, which are essential factors in determining the dividend yield.

JNJ's dividend payments have been consistently higher over the past 120 months, averaging 5.93% per share, showing a steady increase in dividend yield over time.

For more insights, see: Earnings per Share of Common Stock

The recent dividend performance of Johnson & Johnson (JNJ) is a story of consistency. Over the past few years, JNJ has paid a dividend of $1.24 on August 27, 2024, and a dividend of $1.19 on May 20, 2024.

One of the most notable trends in JNJ's recent dividend performance is the relatively stable dividend amount. Since May 2024, JNJ has paid a consistent dividend of $1.24, with a yield of 3.18% on multiple occasions.

Here's a breakdown of JNJ's recent dividend payments:

JNJ's consistent dividend payments are a testament to the company's financial stability and commitment to its shareholders.

Johnson & Johnson's dividend yield is 3.32%, which is higher than the Healthcare sector average of 1.95%. This means JNJ's dividend yield is 70% higher than its sector peers.

Let's take a look at how JNJ's dividend yield compares to its peers in the industry. Here's a table showing the dividend yield, dividend per share (DPS), and payout ratio for some of JNJ's competitors:

JNJ's dividend yield is lower than some of its competitors, such as Novartis AG, but higher than others, like Abbott Laboratories.

Johnson & Johnson's dividend yield is a key metric for investors to consider. JNJ's dividend yield graph provides a visual representation of the company's historical dividend yield over the last 12 months.

JNJ has a dividend yield of 3.32%, which is higher than the Healthcare sector average of 1.95%. This is a notable difference, with JNJ's yield being 70% higher than the sector average.

Historically, JNJ's dividend yield has averaged 2.7% in the last 5 years, which is less than the current yield. This suggests that the company's dividend payments have become more attractive in recent times.

Investors should consider JNJ's dividend yield in the context of its industry average, which is higher than the company's current yield. This indicates that JNJ's dividend yield is relatively competitive within its industry.

Worth a look: Current Yield versus Yield to Maturity